Douglass EC - Search Results

1

A phase I study of ifosfamide with Mesna given daily for 3 consecutive days to children with malignant solid tumors.

Pratt CB, Meyer WH, Douglass EC, Bowman L, Wilimas J, Ochs J, Marina N, Avery L, Thompson EI. Pratt CB, et al. Among authors: douglass ec. Cancer. 1993 Jun 1;71(11):3661-5. doi: 10.1002/1097-0142(19930601)71:11<3661::aid-cncr2820711131>3.0.co;2-w. Cancer. 1993. PMID: 8490914 Clinical Trial.

2

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors.

Marina NM, Rodman J, Shema SJ, Bowman LC, Douglass E, Furman W, Santana VM, Hudson M, Wilimas J, Meyer W, et al. Marina NM, et al. J Clin Oncol. 1993 Mar;11(3):554-60. doi: 10.1200/JCO.1993.11.3.554. J Clin Oncol. 1993. PMID: 8445431 Clinical Trial.

3

Phase II trial of ifosfamide in children with malignant solid tumors.

Pratt CB, Horowitz ME, Meyer WH, Etcubanas E, Thompson EI, Douglass EC, Wilimas JA, Hayes FA, Green AA. Pratt CB, et al. Among authors: douglass ec. Cancer Treat Rep. 1987 Feb;71(2):131-5. Cancer Treat Rep. 1987. PMID: 3100034

4

Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors.

Pratt CB, Meyer WH, Howlett N, Douglass EC, Bowman LC, Poe D, Mounce K, Kun LE, Houghton JA. Pratt CB, et al. Among authors: douglass ec. Cancer. 1994 Nov 1;74(9):2593-8. doi: 10.1002/1097-0142(19941101)74:9<2593::aid-cncr2820740930>3.0.co;2-c. Cancer. 1994. PMID: 7923016 Clinical Trial.

5

Refining therapeutic strategies for patients with resistant Wilm's tumor.

Marina NM, Wilimas JA, Meyer WH, Jones DP, Douglass EC, Pratt CB. Marina NM, et al. Among authors: douglass ec. Am J Pediatr Hematol Oncol. 1994 Nov;16(4):296-300. Am J Pediatr Hematol Oncol. 1994. PMID: 7978044

6

Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.

Marina NM, Shema SJ, Bowman LC, Rodman J, Douglass EC, Furman WL, Pappo A, Santana VM, Hudson M, Meyer WH, et al. Marina NM, et al. Among authors: douglass ec. Med Pediatr Oncol. 1994;23(4):328-34. doi: 10.1002/mpo.2950230403. Med Pediatr Oncol. 1994. PMID: 8058003

7

Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide.

Gururangan S, Bowman LC, Parham DM, Wilimas JA, Rao B, Pratt CB, Douglass EC. Gururangan S, et al. Among authors: douglass ec. Cancer. 1993 Apr 15;71(8):2653-9. doi: 10.1002/1097-0142(19930415)71:8<2653::aid-cncr2820710834>3.0.co;2-#. Cancer. 1993. PMID: 8453588

8

A phase I study of ifosfamide given on alternate days to treat children with brain tumors.

Pratt CB, Douglass EC, Kovnar EH, Heideman R, Kun L, Avery L, Kellie SJ. Pratt CB, et al. Among authors: douglass ec. Cancer. 1993 Jun 1;71(11):3666-9. doi: 10.1002/1097-0142(19930601)71:11<3666::aid-cncr2820711132>3.0.co;2-e. Cancer. 1993. PMID: 8490915 Clinical Trial.

9

Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.

Pratt CB, Douglass EC, Etcubanas E, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA. Pratt CB, et al. Among authors: douglass ec. Semin Oncol. 1989 Feb;16(1 Suppl 3):51-5. Semin Oncol. 1989. PMID: 2495567

10

Ifosfamide in pediatric malignant solid tumors.

Pratt CB, Douglass EC, Etcubanas EL, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA. Pratt CB, et al. Among authors: douglass ec. Cancer Chemother Pharmacol. 1989;24 Suppl 1:S24-7. doi: 10.1007/BF00253234. Cancer Chemother Pharmacol. 1989. PMID: 2503257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters